Annual Meeting 2008
Safety and Risk Management in Translational Medicine
April 17 – 19, 2008, Weimar (Germany)
The Annual Meeting 2008 focused on discussing techniques, systems and strategic approaches to improve the safety of study participants, to minimize their risk of serious adverse reactions and to improve the predictivity of the safety profile of a new compound. Concepts and guidelines for the new regulatory environment for Phase I studies in the EU were presented. Experts from all involved research areas shared their experiences, discussed their limitations in interpreting the clinical relevance of their studies‘ results and presented their concepts for improving the drug development process.
Program of the Annual Meeting 2008:
AGAH 2008 ThirdA.pdf(681 kB)